Specify a stock or a cryptocurrency in the search bar to get a summary
Revelation Biosciences Inc
REVBRevelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California. Address: 4660 La Jolla Village Drive, San Diego, CA, United States, 92122
Analytics
WallStreet Target Price
14.45 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures REVB
Dividend Analytics REVB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History REVB
Stock Valuation REVB
Financials REVB
Results | 2019 | Dynamics |